Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease

Bibliographic Details
Main Authors: Giulio Cavalli, Alessandro Tomelleri, Giacomo De Luca, Corrado Campochiaro, Charles A. Dinarello, Elena Baldissera, Lorenzo Dagna
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Arthritis Research & Therapy
Online Access:http://link.springer.com/article/10.1186/s13075-019-1843-9

Internet

http://link.springer.com/article/10.1186/s13075-019-1843-9

Similar Items